The Miami Project Successfully Completes Schwann Cell Transplantation Safety Trial

Home/News/News/The Miami Project Successfully Completes Schwann Cell Transplantation Safety Trial

The Miami Project Successfully Completes Schwann Cell Transplantation Safety Trial

The Miami Project to Cure Paralysis, a Center of Excellence at the University of Miami Miller School of Medicine, has published the findings of its first Food and Drug Administration-approved Phase I clinical trial involving the use of human nerve cells to repair a damaged spinal cord.

The cells, known as Schwann cells, are essential for the repair of nerve damage, and have long been thought capable of promoting recovery after spinal cord injury. The trial, performed at University of Miami/Jackson Memorial Hospital, is the first in a series designed to evaluate the safety and feasibility of transplanting autologous human Schwann cells to treat individuals with spinal cord injuries.


Original source of this content: https://www.healthcanal.com/brain-nerves/235815-miami-project-successfully-completes-schwann-cell-transplantation-safety-trial.html